The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Exciting new antibody targets all cancers, starting with AML; clinical trials at Oxford University a

stemcellbuff
stemcellbuff CSN Member Posts: 1
edited November 2013 in Leukemia #1

The first drug to target a mutation common to all cancers goes to trial soon in the US and UK, Stanford and Oxford. Solid cancers in one trial, AML in the other. Trial headed by stem cell pioneer Irving Weissman of Stanford Univerity.  Many peer reviewed journal papers are mentioned at below link for review. Good luck!

http://www.dddmag.com/articles/2013/10/trial-may-fight-first-common-target-all-human-cancers

Like Care

Comments

  • GSRon
    GSRon CSN Member Posts: 1,303 Member
    #2
    CD47

    Hi All..!!  Yes CD47 brings a lot of hope for many kinds of Cancer.  The first human testing was to start this year.. then early next year.. now mid 2014.  Check out this link..  http://stemcell.stanford.edu/CD47/

     

    Be Well All..!

     

    Ron mRCC

    Like Care

Discussion Boards